Matthew Nieder
About
In The Last Decade
Matthew Nieder
14 papers receiving 379 citations
Peers
Comparison fields: 5 of 77
- Molecular Biology 215
- Pollution 91
- Oncology 79
- Plant Science 79
- Genetics 64
Countries citing papers authored by Matthew Nieder
This map shows the geographic impact of Matthew Nieder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Nieder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Nieder more than expected).
Fields of papers citing papers by Matthew Nieder
This network shows the impact of papers produced by Matthew Nieder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Nieder. The network helps show where Matthew Nieder may publish in the future.
Co-authorship network of co-authors of Matthew Nieder
This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Nieder. A scholar is included among the top collaborators of Matthew Nieder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Nieder. Matthew Nieder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 10 | |
| 3 | CD10 is a key enzyme involved in the activation of tumor-activated peptide prodrug CPI-0004Na and novel analogues: implications for the design of novel peptide prodrugs for the therapy of CD10+ tumors. | 24 |
| 4 | CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity. | 26 |
| 5 | 9 | |
| 6 | 38 | |
| 7 | 67 | |
| 8 | [Studies of the pharmacokinetics and bioavailability of a new trimethoprim/sulfamethoxazole preparation in healthy volunteers]. | 5 |
| 9 | 23 | |
| 10 | [The pharmacokinetics and bioavailability of urapidil. In vitro/in vivo correlations of different experimental formulations]. | 1 |
| 11 | 25 | |
| 12 | [Comparative studies on the in vitro dissolution and bioavailability of various acetylsalicylic acid preparations]. | 1 |
| 13 | 121 | |
| 14 | 58 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.